Analystreport

Oyster Point Pharma, Inc. (NASDAQ: OYST) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $22.00 price

Oyster Point Pharma, Inc. - common stock  (OYST) 
Last oyster point pharma, inc. - common stock earnings: 2/27 04:01 pm Check Earnings Report